A nationwide $90 million settlement with drugmaker GlaxoSmithKline LLC will bring more than $2.1 million to the Commonwealth, according to state Attorney General Martha Coakley.
Coakley's office has joined 37 other states in the settlement with GlaxoSmithKline, which resolves allegations the pharmaceutical company unlawfully promoted its diabetes drug, Avandia, by misrepresenting its cardiovascular risks and safety profile.
"When pharmaceutical companies misrepresent the safety of their drugs, they put patients at risk," Coakley said. "This settlement helps ensure that consumers will be protected from misleading marketing that can result in the unsafe use of prescription drugs."
Coakley's office alleged GSK promoted the diabetes drug to physicians and other health-care providers with false and misleading representations about its safety and misrepresented the drug's cardiovascular benefits when, in fact, the drug may instead increase risks, all in order to increase their sales of Avandia in the Bay State.
The $2.1 million settlement includes $100,000 for fees and investigative costs, while the remaining funds will pay for programs that lower costs for Massachusetts residents, combat unlawful marketing practices or benefit health-care consumers, Coakley said.
As part of the settlement, GSK agreed to reform how it markets and promotes diabetes drugs, and is prohibited from making any false or deceptive claims about any diabetes drug; making comparative safety claims not supported by substantial evidence or clinical experience; promoting investigational drugs; presenting favorable information previously thought of as valid but rendered invalid by contrary and more credible recent information and misusing statistics or otherwise misrepresenting the nature, applicability or significance of clinical trials.
The consent judgment is in addition to a settlement announced in July when Coakley obtained more than $35 million from GSK, on behalf of the Massachusetts Medicaid Program, due to its unlawful marketing of a number of drugs, including Avandia.
Anda sedang membaca artikel tentang
Glaxo's Avandia settlement will mean $2.1M for Massachusetts
Dengan url
http://wartawanlocal.blogspot.com/2012/11/glaxos-avandia-settlement-will-mean-21m.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Glaxo's Avandia settlement will mean $2.1M for Massachusetts
namun jangan lupa untuk meletakkan link
Glaxo's Avandia settlement will mean $2.1M for Massachusetts
sebagai sumbernya
0 komentar:
Posting Komentar